Results 141 to 150 of about 148,179 (289)
The Versatile Applications of Antisense Oligonucleotides in Modern Medicine. [PDF]
Liang XH, Zhang L.
europepmc +1 more source
Combining synthetic cells engineering, cell‐free expression, and optical regulation may enable a new generation of programmable synthetic cell platforms. By providing spatiotemporal control over biomolecule synthesis, activation, transport, release, and communication, light offers a versatile strategy for coordinating proteins, RNAs, peptides, and ...
Gia Bao Leon Hoang, Taniya Chakraborty
wiley +1 more source
Survivin-Targeting Antisense Oligonucleotides in Cancer Therapy. [PDF]
Poudel BH, Chen S, Veedu RN.
europepmc +1 more source
Chronic Non‐Progressive Neurophysiology in an ALS Patient Treated With Tofersen for 6 Years
Muscle &Nerve, EarlyView.
Ivar Winroth +6 more
wiley +1 more source
The mitogenome was transcribed into complete primary polycistrons on both strands. The heteropteran mitochondrial transcription termination factor (HmTTF) functions as a bidirectional attenuator rather than a terminator, and co‐evolution of HmTTF and the binding sites was observed.
Shiwen Xu +6 more
wiley +1 more source
Use of conformationally locking antisense oligonucleotides for the targeted inhibition of precursor microRNAs. [PDF]
Westwood MN +4 more
europepmc +1 more source
ABSTRACT Background The most prevalent solid tumors in young men are testicular germ cell tumors (TGCTs), and embryonal carcinoma is the most common subtype among non‐seminomatous germ cell tumors (NSGCTs). Despite the excellent cure rates of cisplatin‐based chemotherapy, resistance develops in 15%–30% of patients with metastatic cancer, which results ...
Marco De Martino +5 more
wiley +1 more source
Antisense oligonucleotides-mediated rescue of the <i>AMELX</i> splicing defects. [PDF]
Cho ES +6 more
europepmc +1 more source
Building a precision therapeutics program at a tertiary care children's hospital
Pediatric Investigation, EarlyView.
Luke Hamilton +8 more
wiley +1 more source
Peripheral targets for neuropathic pain
Neuropathic pain represents a significant clinical challenge, with still limited pharmacological approaches to symptomatic relief. This review focuses on molecular targets implicated in neuropathic pain, particularly those involved in peripheral mechanisms. Using the IUPHAR/BPS database of biological targets, their occurrence together with ‘neuropathic
Amirhossein Afsharipour +3 more
wiley +1 more source

